Live Breaking News & Updates on Desmoid Tumors Published

Stay updated with breaking news from Desmoid tumors published. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

SpringWorks Therapeutics Reports First Quarter 2023 Financial Results and Recent Business Highlights

– NDA for Nirogacestat in Adults with Desmoid Tumors Accepted by the FDA and Granted Priority Review; PDUFA Action Date Set for August 27, 2023 – – Phase 3 DeFi Trial Evaluating. | May 3, 2023 ....

United States , Saqib Islam , Samantha Hilson Sandler , Trademark Office , Springworks Therapeutics Inc , Development Rd Expenses , European Medicines Agency , American Association For Cancer Research Annual Meeting , Drug Administration , American Association For Cancer Research , Desmoid Tumors Accepted , Granted Priority Review , Date Set , Desmoid Tumors Published , New England Journal , Encouraging Clinical Data , Tumor Programs Presented , American Association , Cancer Research Annual Meeting , Works Therapeutics , New Drug Application , Priority Review , Chief Executive Officer , Business Highlights , Springwork New Drug Application , Prescription Drug User Fee Act ,